What Characteristics at Baseline Are Associated with the Glucose-Lowering Effect of Colestimide in Patients with Type 2 Diabetes with Hypercholesterolemia?

被引：0
|
作者：
Suzuki, Tatsuya
Watanabe, Kentaro
Ouchi, Motoshi
Suzuki, Kazunari
Sekimizu, Kenichi
Nakano, Hiroshi
Oba, Kenzo
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2354-PO
引用
收藏
页码：A626 / A626
页数：1
相关论文
共 50 条
  • [41] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Donnelly, Peter E.
    Winch, Denis E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07): : 670 - 671
  • [42] Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes Mellitus
    Jung, Jin Ah
    Kaku, Kohei
    Kim, Jae Hyeon
    Kim, Jung-Ryul
    Ko, Jae-Wook
    Lee, Soo-Youn
    Huh, Wooseong
    ADVANCES IN THERAPY, 2013, 30 (11) : 1018 - 1029
  • [43] Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis
    Xie, Wenting
    Su, Fugui
    Wang, Guizhong
    Peng, Zichong
    Xu, Yaomin
    Zhang, Yi
    Xu, Ningning
    Hou, Kaijian
    Hu, Zhuping
    Chen, Yan
    Chen, Rongping
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [44] Association study of six type 2 diabetes genes and glucose-lowering effect of sulfonylurea drugs
    Schroner, Z.
    Javorsky, M.
    Klimcakova, L.
    Dobrikova, M.
    Habalova, V.
    Babjakova, E.
    Zidzik, J.
    Fabianova, M.
    Slaba, E.
    Kozarova, M.
    Tkacova, R.
    Salagovic, J.
    Tkac, I.
    DIABETOLOGIA, 2011, 54 : S123 - S123
  • [45] Intensive glucose-lowering in type 2 diabetes was linked to hypoglycemia in high-complexity patients
    Steinberg, Daniel I.
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (06) : JC33 - JC33
  • [46] Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes Mellitus
    Jin Ah Jung
    Kohei Kaku
    Jae Hyeon Kim
    Jung-Ryul Kim
    Jae-Wook Ko
    Soo-Youn Lee
    Wooseong Huh
    Advances in Therapy, 2013, 30 : 1018 - 1029
  • [47] Cardiovascular prevention in type 2 diabetes mellitus patients: the role of oral glucose-lowering agents
    Anselmino, Matteo
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (06) : 427 - 433
  • [48] New glucose-lowering drugs for reducing cardiovascular risk in patients with type 2 diabetes mellitus
    Gorgojo-Martinez, J. J.
    HIPERTENSION Y RIESGO VASCULAR, 2019, 36 (03): : 145 - 161
  • [49] Concomitant use of benzodiazepines and oral glucose-lowering drugs in patients with type-2 diabetes
    Fornero, Agostina
    Bertoldo, Pamela
    Dumont, Nilda
    FARMACEUTICOS COMUNITARIOS, 2018, 10 (01): : 41 - 46
  • [50] Effect of new glucose-lowering drugs on stroke in patients with type 2 diabetes: A systematic review and Meta-analysis*
    Li, Jiaxi
    Ji, Cheng
    Zhang, Wen
    Lan, Linyan
    Ge, Weihong
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (01)
12345